BioSpace News Archive

Fulcrum Therapeutics, Inc. (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined rare diseases, today announced that Bryan E. Stuart, the company’s chief operating officer, will become Fulcrum’s president and chief executive officer and will be appointed to the Board of Directors.

Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders including Alzheimer’s disease,

VBL Therapeutics (Nasdaq: VBLT) today announced the online publication of positive results of the pre-specified interim analysis of the OVAL study, a Phase 3 registration enabling study of VB-111 (ofranergene obadenovec) in recurrent platinum-resistant ovarian cancer.

Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced its operational and financial results for the fourth quarter and full year ended December 31, 2020.

Alternating, intravenous administration of two replicating arenaviral vectors induce tumor-specific responses exceeding 50% of the circulating CD8 T cells 2-vector approach resulted in tumor cures and long-term immunity against tumor rechallenge Publication underscores the potential of HOOKIPA’s engineered arenavirus platform as a new class of cancer immunotherapeutics, currently being evaluated in a Phase 1/2 clinical trial in HPV16+ cancers

CollPlant (NASDAQ: CLGN), a regenerative and aesthetics medicine company, today announced that Mr. Yehiel Tal , Chief Executive Officer of CollPlant, will provide an overview of the company at the H.C. Wainwright Global Life Sciences Conference which will be held virtually on March 9-10, 2021 .

High demand for precision based and automated surgical solutions to improve patient outcomes to stimulate demand

Interferons are a class of proteins produced by the immune system as a response against viral infections, bacteria, tumor cells, and other pathogens.

A Holter ECG monitor continuously tracks various electrical activities of the cardiovascular system and records electrocardiogram of arrhythmia patients.

The IVF services market is witnessing an upsurge mainly because of the high success rates of conception associated with IVF.